- Home
- JSPRW vs EFT Comparison
JSPRW vs EFT Comparison
Compare JSPRW & EFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPRW
- EFT
- Stock Information
- Founded
- JSPRW N/A
- EFT 2004
- Country
- JSPRW United States
- EFT United States
- Employees
- JSPRW 45
- EFT N/A
- Industry
- JSPRW Biotechnology: Pharmaceutical Preparations
- EFT Finance Companies
- Sector
- JSPRW Health Care
- EFT Finance
- Exchange
- JSPRW Nasdaq
- EFT Nasdaq
- Market Cap
- JSPRW N/A
- EFT N/A
- IPO Year
- JSPRW 2020
- EFT N/A
- Fundamental
- Price
- JSPRW $0.22
- EFT $13.32
- Analyst Decision
- JSPRW
- EFT
- Analyst Count
- JSPRW 0
- EFT 0
- Target Price
- JSPRW N/A
- EFT N/A
- AVG Volume (30 Days)
- JSPRW N/A
- EFT 100.8K
- Earning Date
- JSPRW N/A
- EFT 01-01-0001
- Dividend Yield
- JSPRW N/A
- EFT 10.63%
- EPS Growth
- JSPRW N/A
- EFT N/A
- EPS
- JSPRW N/A
- EFT 1.73
- Revenue
- JSPRW N/A
- EFT N/A
- Revenue This Year
- JSPRW N/A
- EFT N/A
- Revenue Next Year
- JSPRW N/A
- EFT N/A
- P/E Ratio
- JSPRW N/A
- EFT $7.62
- Revenue Growth
- JSPRW N/A
- EFT N/A
- 52 Week Low
- JSPRW N/A
- EFT $11.10
- 52 Week High
- JSPRW N/A
- EFT $13.44
- Technical
- Relative Strength Index (RSI)
- JSPRW N/A
- EFT 46.25
- Support Level
- JSPRW N/A
- EFT $13.29
- Resistance Level
- JSPRW N/A
- EFT $13.55
- Average True Range (ATR)
- JSPRW 0.00
- EFT 0.12
- MACD
- JSPRW 0.00
- EFT -0.02
- Stochastic Oscillator
- JSPRW 0.00
- EFT 17.77
About JSPRW Japer Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.